Menu
No results found.
Weekly Share Price & Valuation Overview
Anhui Huaheng Biotechnology Co., Ltd.
Anhui Huaheng Biotechnology Co., Ltd. engages in the development, production, and sale of amino acids and other organic acids in China and internationally. The company offers inositol, D-calcium pantothenate, L-valine, DL- alanine, L-citrulline, DL-malic acid, L-alanine, D-panthenol, L-citrulline DL-malate, L-malic acid, beta-alanine, a- arbutin, L-arginine, ß-arbutin, L-glycine, L-proline, amino acid concentrate, compound amino acid power, microbial inoculum, compound microbial fertilizer, and water soluble fertilizer products. Its products are used in daily chemical, medicine, health and personal care products, food additives, feeds, animal nutrition, plant nutrition, and functional nutrition. The company was formerly known as Anhui Huaheng Biological Engineering Co., Ltd. and changed its name to Anhui Huaheng Biotechnology Co., Ltd. in November 2013. The company was founded in 2005 and is based in Hefei, China.
- Revenue growth ≥10% indicates solid top-line momentum.
- Quick ratio <0.8 — tight near-term liquidity without inventory.
- Debt/EBITDA >4 — elevated leverage vs earnings capacity.
- Market Cap Total equity value of the company (share price × shares outstanding).
- CNY 9.01B
- Enterprise Value Operating value: market cap + total debt − cash.
- CNY 10.41B
- Total Revenue (TTM) Sales over the last twelve months. May be estimated from revenue per share when inconsistent.
- CNY 2.36B
- Gross Profit (TTM) Revenue minus cost of goods sold over the last twelve months. Hidden for financial institutions or if redundant.
- CNY 538.52M
- EBITDA (TTM) Earnings before interest, taxes, depreciation and amortization (TTM). Hidden for financials or if implausible.
- CNY 316.70M
- Revenue per Share (TTM) Total revenue divided by shares outstanding (may be estimated).
- CNY 10.14
- EPS (TTM) Earnings per share over the last twelve months (may be estimated from net income ÷ shares).
- 0.67
- Shares Outstanding
- 250.12M
- Float Shares
- 155.37M
- Implied Shares Outstanding
- 250.08M
- Operating Margin (TTM) Operating income ÷ revenue over the last twelve months (reconciled when possible).
-
8.76%
- EBITDA Margin (TTM) Reconciled EBITDA ÷ revenue over the last twelve months (suppressed if EBITDA implausible/financials).
-
13.40%
- Gross Margin (TTM) Reconciled Gross profit ÷ revenue over the last twelve months (reconciled when possible).
-
22.78%
- Profit Margin (TTM) Net income ÷ revenue over the last twelve months (reconciled when possible).
-
6.52%
- ROE Return on equity: net income ÷ shareholder equity.
-
6.67%
- Revenue Growth Strong Year-over-year revenue growth.
-
37.20%
- Earnings Growth (YoY) Year-over-year earnings growth.
-
-42.90%
- Earnings Growth (QoQ) Quarter-over-quarter earnings growth.
-
-41.00%
- Quick Ratio Liquid current assets ÷ current liabilities (ex-inventory).
- 0.57
- Debt to Equity Total debt ÷ shareholder equity; leverage.
- 0.62
- Total Cash Cash and equivalents.
- CNY 417.92M
- Total Debt Short + long-term interest-bearing debt.
- CNY 1.63B
- Net Debt Total debt − cash (negative = net cash).
- CNY 1.21B
- Debt / EBITDA Leverage relative to operating earnings; lower is safer.
- 5.15
- Operating Cash Flow (TTM) Cash generated by core operations (pre-capex).
- CNY 318.93M
- OCF Margin (TTM) Operating cash flow ÷ revenue (TTM).
-
13.49%
- Cash Conversion (OpCF/EBITDA)
- 1.01
- Dividend Yield suppressed due to an anomalous value from the feed (>30%).
- Margins shown on a TTM basis. “Reconciled” = numerator ÷ TTM revenue for internal consistency.
- Cash Flow section is displayed only when figures are self-consistent (and hidden for financials).
Disclaimer: Information is compiled from publicly available sources and is subject to errors and omissions. It is provided as a guide only and does not constitute investment advice. Please do your own research.